When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BioLineRx ( NASDAQ: BLRX ) has appointed Tami Rachmilewitz, M.D., as Chief Medical Officer, effective January 4, 2023.
Dr. Rachmilewitz brings over 15 years of clinical development industry experience to the Company, including overseeing clinical development programs in oncology, immunology, and neurodegeneration.
Previously, she was Senior Vice President of Clinical Development at VBL Therapeutics.